Retatrutide appears to be a new treatment in the fight against obesity. This novel drug, classified as a dual GLP-1 and GIP receptor agonist, demonstrates promising results in research studies. By stimulating these https://aadamydin895288.therainblog.com/35045664/tirzepatide-a-promising-new-treatment-for-obesity